Related Experiment Video
Updated: May 24, 2026

Induction of Petite Colonies in Candida glabrate via Rose Bengal-Mediated Photodynamic Therapy
Published on: March 29, 2024
Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™)
Ah Young Cho1, Dae Hun Kim, Myung Im
1Department of Dermatology, College of Medicine, Chungnam National University, Daejeon, Korea.
Abstract:
Imatinib mesylate (Gleevec™, STI571), a selective inhibitor of BCR-ABL, c-Kit, and platelet-derived factor receptor, has been used to treat chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors. Although its use has been associated with various adverse cutaneous reactions, pityriasis rosea-like drug eruptions are rare. Here, we report a case of pityriasis rosea-like drug eruption that developed following the administration of imatinib mesylate to treat CML.
Related Concept Videos
Allergic Drug Reactions
Drug Toxicity: Allergic Reactions
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Drug toxicity: Idiosyncratic Reactions
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
